These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 24337478)

  • 21. BRCA1 haploinsufficiency cell-autonomously activates RANKL expression and generates denosumab-responsive breast cancer-initiating cells.
    Cuyàs E; Corominas-Faja B; Martín MM; Martin-Castillo B; Lupu R; Brunet J; Bosch-Barrera J; Menendez JA
    Oncotarget; 2017 May; 8(21):35019-35032. PubMed ID: 28388533
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Stress and the menstrual cycle: relevance of cycle quality in the short- and long-term response to a 5-day endotoxin challenge during the follicular phase in the rhesus monkey.
    Xiao E; Xia-Zhang L; Barth A; Zhu J; Ferin M
    J Clin Endocrinol Metab; 1998 Jul; 83(7):2454-60. PubMed ID: 9661628
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression of osteoprotegerin (OPG), TNF related apoptosis inducing ligand (TRAIL), and receptor activator of nuclear factor kappaB ligand (RANKL) in human breast tumours.
    Van Poznak C; Cross SS; Saggese M; Hudis C; Panageas KS; Norton L; Coleman RE; Holen I
    J Clin Pathol; 2006 Jan; 59(1):56-63. PubMed ID: 16394281
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Features of breast ultrasound image and its correlation with estradiol and progesterone level in different phases of menstrual cycle in normal women].
    Zhou YZ; Jiang YX; Sun Q; Zhang SQ; Zhang Y; Chen FL; Lin SQ
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2001 Dec; 23(6):609-13. PubMed ID: 12901108
    [TBL] [Abstract][Full Text] [Related]  

  • 25. RANKL and RANK in sex hormone-induced breast cancer and breast cancer metastasis.
    Schramek D; Sigl V; Penninger JM
    Trends Endocrinol Metab; 2011 May; 22(5):188-94. PubMed ID: 21470874
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differential expression of progesterone receptor, FOXA1, GATA3, and p53 between pre- and postmenopausal women with estrogen receptor-positive breast cancer.
    Hosoda M; Yamamoto M; Nakano K; Hatanaka KC; Takakuwa E; Hatanaka Y; Matsuno Y; Yamashita H
    Breast Cancer Res Treat; 2014 Apr; 144(2):249-61. PubMed ID: 24549642
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MPA influences tumor cell proliferation, migration, and invasion induced by RANKL through PRB involving the MAPK pathway in endometrial cancer.
    Wang J; Sun X; Zhang H; Wang Y; Li Y
    Oncol Rep; 2015 Feb; 33(2):799-809. PubMed ID: 25483570
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Progesterone drives mammary secretory differentiation via RankL-mediated induction of Elf5 in luminal progenitor cells.
    Lee HJ; Gallego-Ortega D; Ledger A; Schramek D; Joshi P; Szwarc MM; Cho C; Lydon JP; Khokha R; Penninger JM; Ormandy CJ
    Development; 2013 Apr; 140(7):1397-401. PubMed ID: 23462470
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effects of cocaine on basal and human chorionic gonadotropin-stimulated ovarian steroid hormones in female rhesus monkeys.
    Mello NK; Mendelson JH; Kelly M; Bowen CA
    J Pharmacol Exp Ther; 2000 Sep; 294(3):1137-45. PubMed ID: 10945870
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Bone metastasis and RANKL].
    Nakashima T
    Clin Calcium; 2014 Aug; 24(8):1201-8. PubMed ID: 25065872
    [TBL] [Abstract][Full Text] [Related]  

  • 31. What regulates placental steroidogenesis in 90-day pregnant ewes?
    Weems YS; Kim L; Tsuda V; Yin C; Weems CW
    Prostaglandins Other Lipid Mediat; 2007 Aug; 84(1-2):54-65. PubMed ID: 17643888
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Functional luteolysis in the rhesus monkey: ovarian estrogen and progesterone during the luteal phase of the menstrual cycle.
    Butler WR; Hotchkiss J; Knobil E
    Endocrinology; 1975 Jun; 96(6):1509-12. PubMed ID: 1126318
    [TBL] [Abstract][Full Text] [Related]  

  • 33. RANKL/RANK - from bone physiology to breast cancer.
    Sigl V; Penninger JM
    Cytokine Growth Factor Rev; 2014 Apr; 25(2):205-14. PubMed ID: 24486161
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gonadotrophin dependence of steroidogenesis by human corpora lutea of different ages during the menstrual cycle.
    Yamoto M; Ikoma H; Nakano R
    Gynecol Obstet Invest; 1988; 26(3):225-31. PubMed ID: 3240890
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression profile of receptor activator of nuclear-κB (RANK), RANK ligand (RANKL) and osteoprotegerin (OPG) in breast cancer.
    Owen S; Ye L; Sanders AJ; Mason MD; Jiang WG
    Anticancer Res; 2013 Jan; 33(1):199-206. PubMed ID: 23267146
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Estrogen induces premature luteal regression in rhesus monkeys during spontaneous menstrual cycles, but not in cycles driven by exogenous gonadotropin-releasing hormone.
    Hutchison JS; Kubik CJ; Nelson PB; Zeleznik AJ
    Endocrinology; 1987 Aug; 121(2):466-74. PubMed ID: 3297646
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Luteal phase support in ART treatments.
    Or Y; Vaisbuch E; Shoham Z
    Methods Mol Biol; 2014; 1154():251-60. PubMed ID: 24782012
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Targeting RANKL in breast cancer: bone metastasis and beyond.
    Azim H; Azim HA
    Expert Rev Anticancer Ther; 2013 Feb; 13(2):195-201. PubMed ID: 23406560
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression of receptor activator of nuclear factor kappa-B as a poor prognostic marker in breast cancer.
    Park HS; Lee A; Chae BJ; Bae JS; Song BJ; Jung SS
    J Surg Oncol; 2014 Dec; 110(7):807-12. PubMed ID: 25111682
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Progesterone levels in breast duct fluid.
    Rose DP; Tilton K; Lahti H; Wynder EL
    Eur J Cancer Clin Oncol; 1986 Jan; 22(1):111-3. PubMed ID: 3956554
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.